How big is the Syndromic Multiplex Diagnostic Market?

The Syndromic Multiplex Diagnostic Market size is expected to reach USD 2.68 billion in 2024 and grow at a CAGR of 7.66% to reach USD 3.89 billion by 2029. Read More

What is the current Syndromic Multiplex Diagnostic Market size?

In 2024, the Syndromic Multiplex Diagnostic Market size is expected to reach USD 2.68 billion. Read More

Who are the key players in Syndromic Multiplex Diagnostic Market?

Akonni Biosystems, Applied BioCode, QIAGEN, BIOMERIEUX SA and DiaSorin S.p.A (Luminex Corporation) are the major companies operating in the Syndromic Multiplex Diagnostic Market. Read More

Which is the fastest growing region in Syndromic Multiplex Diagnostic Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Syndromic Multiplex Diagnostic Market?

In 2024, the North America accounts for the largest market share in Syndromic Multiplex Diagnostic Market. Read More

What years does this Syndromic Multiplex Diagnostic Market cover, and what was the market size in 2023?

In 2023, the Syndromic Multiplex Diagnostic Market size was estimated at USD 2.49 billion. The report covers the Syndromic Multiplex Diagnostic Market historical market size for years: 2021, 2022 and 2023. The report also forecasts the Syndromic Multiplex Diagnostic Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Syndromic Multiplex Diagnostic Companies

This report lists the top Syndromic Multiplex Diagnostic companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Syndromic Multiplex Diagnostic industry.